Giulia Elda Valenti

11PUBLICATIONS
30CO-AUTHORS
Molecular targetsPredictive and prognostic markersBiomolecular modelling and designMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 28, 2026
Design and Synthesis of New Coumarin Hybrids Active Against Drug-Sensitive and Drug-Resistant Neuroblastoma Cells.

Carola Grondona, Barbara Marengo, Giulia Elda Valenti

|Jun 26, 2025
Targeting the p53/xCT/GSH Axis with PRIMA-1Met Combined with Sulfasalazine Shows Therapeutic Potential in Chronic Lymphocytic Leukemia.

Martina Pasino, Andrea Speciale, Silvia Ravera

|Jan 26, 2024
PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis.

Giulia Elda Valenti, Antonella Roveri, Rina Venerando

|Oct 28, 2023
Antiproliferative Imidazo-Pyrazole-Based Hydrogel: A Promising Approach for the Development of New Treatments for PLX-Resistant Melanoma.

Silvana Alfei, Marco Milanese, Chiara Brullo

|Oct 14, 2023
Imidazo-Pyrazole-Loaded Palmitic Acid and Polystyrene-Based Nanoparticles: Synthesis, Characterization and Antiproliferative Activity on Chemo-Resistant Human Neuroblastoma Cells.

Giulia Elda Valenti, Barbara Marengo, Marco Milanese

|Jul 27, 2022
Anti-Survival Effect of SI306 and Its Derivatives on Human Glioblastoma Cells.

Lorenzo Monteleone, Barbara Marengo, Francesca Musumeci

Pageof 2

Frequent Collaborators

11 joint publications

Barbara Marengo

9 joint publications

Cinzia Domenicotti

5 joint publications

Silvana Alfei

3 joint publications

Bruno Tasso